The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
External validation of previously reported prognostic classifications for patients treated with second-line axitinib after immuno-oncology combination therapy for advanced renal cell carcinoma: JUOG retrospective study.
 
Yu Kujiraoka
No Relationships to Disclose
 
Takahiro Osawa
Honoraria - MSD; Takeda
 
Yuto Matsushita
No Relationships to Disclose
 
Takahiro Kojima
No Relationships to Disclose
 
Hiroaki Hara
No Relationships to Disclose
 
Katsuyoshi Hashine
No Relationships to Disclose
 
Hiroshi Kitamura
Honoraria - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Chugai Pharma; Eisai; Ferring; Janssen; Johnson & Johnson; Merck; MSD; Nippon Kayaku; Nippon Shinyaku; Pfizer; Sanofi; Takeda
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Eisai; Ferring; Janssen; Kissei Pharmaceutical; Takeda
Research Funding - AstraZeneca; Bristol-Myers Squibb; MSD; Takeda
 
Hideaki Miyake
Honoraria - Eisai; MSD; Takeda
 
Nobuo Shinohara
Honoraria - Astellas Pharma; AstraZeneca; Janssen; MSD; Novartis; Ono Pharmaceutical; Pfizer; Takeda
Research Funding - Astellas Pharma (Inst); Ono Pharmaceutical (Inst)